MENU
QURE
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
uniQure (QURE) Ownership - Who owns uniQure?
uniQure NV is a gene therapy company... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
Paasheuvelweg 25
Phone
+31 202406000
Employees
480
Web
https://www.uniqure.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
728.63M
P/E Ratio
N/A
Total Cash
376.97M
Projected Growth
N/A
Total Debt
66.7M
Revenue
14.34M
Risk (Beta)
-0.13
Dividend Yield
N/A
Total Cash/Share
6.87
Total Debt/Equity
N/A
Revenue/Share
0.28 USD as % of share price
Fundamentals
QURE
Capitalization
729M
P/E Ratio
N/A
Risk (Beta)
-0.13
Dividend Yield
N/A
Total Cash
377M
Total Cash/Share
6.87
Total Debt
66.7M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.28%
Revenue
14.3M
ROE
N/A
Book Value
-4M
P/B Ratio
24.33
Cash Flow
N/A
Earnings
-3.9
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
3.25M
Current Ratio
9.98
Current Revenue Per Employee
25177.03
Dividends Per Share - Security
N/A
EBITDA
-119.56M
Float
N/A
Float - Current
N/A
Gross Income Margin
87.53
Revenue To Assets
-30.25
Shares Held By Institutions
695M
Shares Outstanding - Current
54.9M
Total Liabilities
589M
Total Volume MTD
N/A
Value
-1
Gain YTD
-24.802
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. QURE showed earnings on July 29, 2025. You can read more about the earnings report here.
A.I. Advisor
published General Information
General Information
a company which engages in the discovery, development, and commercialization of gene therapies
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
Paasheuvelweg 25
Phone
+31 202406000
Employees
480
Web
https://www.uniqure.com